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RAG knockouts deliver a one/two punch 
Mice lacking recombinase activating gene 1 or 2 are devoid 
of mature 6 and T cells but are otherwise developmentally 
normal. They may be ideal for transplantation studies. 
The ability of mammals to protect themselves from in- 
vasion by foreign cells or pathogens is controlled pri- 
marily by the lymphoid immune system. This system is 
composed of B cells, which produce antibodies, and T 
cells, which direct cell-mediated immune responses, Col- 
lectively, mature B and T cells have the ability to initi- 
ate immune responses against an enormous number of 
foreign antigens. Recognition of antigens by B cells is 
mediated through the variable region of their cell surface 
immunoglobulin receptor (sIg). T-cell antigen recogni 
tion is mediated by the variable domain of the T-cell 
receptor (TCR). The genes that encode the sIg and TCR 
molecules are assembled during B and T cell develop- 
ment, respectively, from individual members of variable 
(V), diversity (D), and joining (J) gene segment families 
in a process known as V(D)J recombination. Although 
V(D)J recombination creates only a single type of TCR 
or sIg in each individual B or T cell, the combinatorial 
diversity of the recombination process generates B and 
T cells ,with > 10s distinct antigenic speciiicities. Subse- 
quent selection processes during B- and T-cell develop- 
ment serve to remove or inactivate cells with receptors 
that react against self-antigens, 
Although many of the c&acting elements that regulate 
the V(D)J recombination process have been defined, rel- 
atively little is known about the V(D)J recombinase it- 
self. Present evidence suggests that the same recombi- 
nase mediates the rearrangement of both immunoglob- 
ulin and T-cell receptor genes. As currently conceived, 
the V(D)J recombinase must be able to carry out a 
series of complex reactions, including: recognition of 
the recombination signal sequences that flank V, D, and 
J elements; precise cleavage of the DNA substrate at 
the border between the signal and coding sequences; 
pairing and ligation of two signal sequences; modifica- 
tion of the end of the coding sequence, including base- 
pair addition and deletion; and coding sequence end- 
ligation (Fig. 1). Based on the large number of events 
that occur during recombination, it has long been as- 
sumed that recombinase activity might require the con- 
certed function of several gene products. Some of the 
recombinase components are likely to be lymphoid-spe- 
ciiic, whereas others may play a more general role in 
DNA repair. Consistent with this hypothesis, the murine 
sad mutation, which involves a generalized deficiency 
in double strand DNA break repair, profoundly inhibits 
the coding sequence ligation step of V(D)J recombi- 
nation [l]. As a result the ability of scid mice to de- 
velop functional B and T cells is impaired and they 
develop a severe combined immunodeficiency. 
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In 1990, two murine genes, recombinase activating gene 
(RAG) 1 and 2, were isolated by virtue of their abil- 
ity to synergistically activate V(D)J recombination in fi- 
broblasts [2]. The two genes are unrelated in amino 
acid sequence but are located only 8 kilobases (kb) apart 
on the same chromosome. Although the 5’untranslated 
regions of the cDNAs of both genes appear to con- 
tain spliced exons, the coding sequences of both RAG- 
1 and RAG-2 are contained within a single exon. The 
two genes and their organization have been highly con- 
served in vertebrate evolution. Coexpression of RAG-l 
and RAG-2 has been observed only in developing lym 
phoid cells and lymphoid cell lines that have V(D)J re- 
combinase activity. Based on these results, it appears 
that RAG-l and RAG-2 together either activate the ex- 
pression of the V(D)J recombinase or are themselves 
both essential components of the recombinase. RAG-l 
has been reported to have limited sequence similarity 
to the yeast gene Hpr-I, which plays a role in regula- 
tion of recombination events in yeast, but RAG-2 has not 
been found to be related to any known gene product. To 
date, the properties of the protein products of RAG-l and 
RAG-2 have not been characterized. Thus, the individual 
roles of these two genes in the regulation of V(D)J re- 
combination has not been established. 
Recombination as a genetic control mechanism has been 
observed frequently in prokatyotes and single cell eukary- 
otes. With the exception of immunoglobulin- and TCR- 
associated recombination events, however, developmen- 
tal recombination has not been observed in vertebrates, 
despite numerous suggestions that recombination may 
have additional roles in vertebrate embryogenesis and 
neural development. It has been speculated that expres- 
sion of either RAG-1 or RAG-2 alone might have roles 
in developmental recombination events that are distinct 
from V(D)J joining. Consistent with this hypothesis, iso- 
lated expression of RAG-l has been reported in the 
murine central nervous system and isolated expression 
of RAG-2 has been observed in the chicken bursa of 
Fabricius [3,4]. The possibility that RAG-1 might play a 
part in the regulation of genetic recombination in the 
brain was increased by recent evidence [5] of the rear- 
rangement of a transgene containing V(D)J recombina- 
tion signal sequences within the central nervous system 
as well as within lymphoid cells - a pattern that mimics 
the expression of RAG-l. 
To test the role of RAG-l and RAG-2 in murine de- 
velopment, separate groups have now performed tar- 
geted disruption of each of the genes in the mouse 
germline and characterized the developmental effects of 
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Fig. 1. Schematic representation of DJ rearrangement catalysed by the V(D)1 recombinase. Once a DJ recombination has occurred, 
the rearranged DJ segment becomes a substrate for a second recombination in which the V segment is joined to the rearranged DJ 
segment. This second rearrangement (not shown) is also directed by recombination signal sequences (red) and catalysed by the V(D)J 
recombinase. 
homozygous deletion of that gene. Mombaerts et al. [6] 
disrupted RAG-l in the mouse germline, while Shinkai et 
al. [7] disrupted RAG-2. Interestingly, both RAG-l and 
RAG-2 deficient mice appear to have identical phenotypes 
- their lymphoid organs are devoid of mature B and 
T cells. The arrest of B- and T-cell development occurs 
at the earliest known stages, preventing a significant ac- 
cumulation of immature lymphoid cells. No observable 
effects on other haematopoietic cell lineages, including 
natural killer cells and myeloid cells, were noted. 
In both sets of mice, it was possible to show that B-lym- 
phoid development had been initiated; pro-B cells were 
detected by means of their immortalization with Abel- 
son murine leukemia virus (A-MULV). Immortalized cells 
from both sets of mice expressed a variety of early B-lin- 
eage markers including the B-lineage isoform of CD45, 
h5, and the non-deleted RAG product. Immunoglobulin 
genes were present only in germline configuration. In 
immortalized pro-B cells from RAG-2 deficient mice, the 
V(D)J recombination defect could be corrected by trans- 
fection of a functional RAG-2 gene. (A similar experiment 
with RAG-l cells has not yet been performed.) These data 
suggest that RAG-deficient B lymphocytes are arrested at 
the point where they might be expected to initiate D to 
J recombination. 
T-cell development in RAG-deficient mice also appears 
to be arrested at a very early stage. Within the thymus, 
cells coexpressing the Thy-l antigen and the a chain 
of the interleukin-2 receptor can be detected. This is 
the phenotype of the earliest T cells that colonize the 
normal thymus. However, the cells have no detectable 
TCR gene rearrangements and do not express CD4 and 
CD8, even though normal thymocytes express these co- 
receptor molecules before expressing T-cell receptors on 
their surface. This suggests, somewhat surprisingly, that 
RAG gene function is necessary before cells acquire CD4 
and CD8 expression. The data suggest that T cells have 
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an intermediate stage of development during which they 
undergo only D to J rearrangement. Apparently T cells 
cannot proceed past this point in development in the 
absence of RAG-l and RAG-2 co-expression. 
Apart from the complete deficiency of B and T cells, 
neither RAG-l nor RAG-2 deficient mice had any ob- 
servable developmental defects. Mating either RAG-l or 
RAG-2 heterozygotes produced homozygotic mutant 
mice at a frequency of approximately 25%. Thus, dis- 
ruption of neither gene resulted in a significant rate 
of embryonic lethality. Both RAG-1 and RAG-2 deficient 
mice were fertile. Both sets of mice have been examined 
in considerable detail for non-lymphoid pathology, but 
there were no observable macroscopic, histochemical, 
or behavioural differences between RAG-deficient mice 
and control litter mates. Together, these results sug- 
gest that neither the recombinase activating genes or 
V(D)J recombinase activity is absolutely required for the 
development of non-lymphoid cells. 
No defects in the development of the central nervous sys- 
tem of RAG-l deficient mice were seen. The animals have 
been observed for up to 21 weeks and have apparently 
failed to develop any neurological abnormalities. The an- 
imals can reportedly see, hear, and feel normally, have 
good motor strength and coordination, and can carry out 
patterned behavior. The gross and histologic anatomy of 
the brain suggested that the disruption of RAG-1 function 
does not interfere with neural development. Thus, preti- 
ously reported [ 51 central nervous system recombination 
events are either not required for neural development or 
do not involve RAG-l. The present data, however, do not 
completely rule out a role for RAG-l in the maintenance 
of the central nervous system. It has been speculated that 
RAG-1 may play a role in the suppression of illegitimate 
recombination in long lived cells such as neurons. Long 
term observation of the animals and repeated histological 
examinations will be needed to address this hypothesis. 
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, As- RAG-1 and RAG-2 deficient animals do not appear 
to have developmental abnormalities outside the lym- 
phoid immune system, the results of Mombaerts et al. 
and Shinkai et al. have important implications for inves- 
tigators who study hematopoietic development. One of 
the major barriers to the study of human hematopoietic 
cells in animal models has been the transplantation bar- 
rier created by the lymphoid immune system. Recently, 
several important human hematological model systems 
have been established using human bone marrow trans- 
planted into immunodeficient mice [8,9]. For example, 
sad mice reconstituted with human bone marrow have 
been used to study human immunodeficiency virus ir- 
fection in vivo as well as to define the in vivo effects 
of human growth factors and chemotherapeutic agents. 
However, the use of scid mice has two potential draw- 
backs: scid mice have a generalized defect in DNA repair, 
and the scid immune defect is leaky. As scid animals age, 
mature B and T cells begin to appear and these cells may 
mediate transplantation rejection in some animals. 
As already noted, mice deficient in RAG-l or RAG-2 have a 
phenotype very similar to that described for scidmice. In 
contrast to scidmice, however, no leakiness has been ob- 
served in the block to lymphocyte development in RAG- 
deficient mice. This suggests that RAG-deficient mice may 
have real advantages for the tissue transplantation studies 
currently being undertaken in either scid or nude mice. 
For example, RAG-deficient mice will be ideal for the 
production of high titer antibodies from myeloma cells 
because they are completely deficient in endogenous an- 
tibody production. RAG-deficient mice should also be 
useful for testing and studying the growth of allogeneic 
and xenogeneic tumours, and they may be even more 
effective than scidmice at supporting long-term growth of 
human hematopoietic cells. If so, RAG-deficient mice may 
be used to facilitate the development of murine models 
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